4-nitroquinoline-1-oxide has been researched along with bromodeoxyuridine in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (45.83) | 18.7374 |
| 1990's | 9 (37.50) | 18.2507 |
| 2000's | 3 (12.50) | 29.6817 |
| 2010's | 1 (4.17) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakanishi, Y; Schneider, EL | 1 |
| Niwa, O; Sugahara, T | 1 |
| Stĕtina, R; Svoboda, J | 1 |
| McFee, AF; Tice, RR | 1 |
| Gebhart, E; Kysela, D; Matthee, H; Nikol, M | 1 |
| Andronova, AV; Makedonov, GP; Shvetsova, TP; Veliev, NM; Zasukhina, GD | 1 |
| Ahmed, FE; Setlow, RB | 1 |
| Hama-Inaba, H; Hieda-Shiomi, N; Sato, K | 1 |
| Bordigoni, P; Chery, M; Gilgenkrantz, S; Gregoire, MJ; Olive, D | 1 |
| Terzi, M; Vergara, R | 1 |
| Ahmed, FE | 1 |
| Hieda-Shiomi, N; Sato, K; Shiomi, T | 1 |
| Itoh, T; Takahashi, H; Yamamoto, Y | 2 |
| Hara, A; Makita, H; Mori, H; Ohnishi, M; Satoh, K; Tamai, Y; Tanaka, T; Torihara, M; Yamahara, J | 1 |
| Inoue, I; Itoh, T; Saka, T; Takahashi, H; Yamamoto, Y | 1 |
| Hara, A; Kawamori, T; Koshimizu, K; Makita, H; Mori, H; Murakami, A; Ohigashi, H; Ohnishi, M; Satoh, K; Tanaka, T | 1 |
| Fujitsuka, H; Hara, A; Makita, H; Mori, H; Satoh, K; Tanaka, T; Tatematsu, N | 1 |
| Hara, A; Kakumoto, M; Kawabata, K; Koshimizu, K; Kuki, W; Maeda, M; Matsunaga, K; Mori, H; Murakami, A; Odashima, S; Ohigashi, H; Ota, T; Satoh, K; Takahashi, Y; Tanaka, T; Yonei, H | 1 |
| Hayashi, H; Ito, T; Kanisawa, M; Kitamura, H; Mitui, H; Okudela, K; Udaka, N | 1 |
| Poot, M; Rabinovitch, PS; Silber, JR | 1 |
| Hirose, Y; Katayama, M; Kohno, H; Kuno, T; Mori, H; Qiao, Z; Sakata, K; Shibata, T; Sugie, S; Tanaka, T; Yamada, Y; Yoshida, K | 1 |
| Bemis, D; Gudas, LJ; Knudsen, B; Tang, XH; Tickoo, S | 1 |
| D'Souza, S; Kang, TM; Lam, K; Miller, JH; Song, LY; Yeh, P | 1 |
24 other study(ies) available for 4-nitroquinoline-1-oxide and bromodeoxyuridine
| Article | Year |
|---|---|
In vivo sister-chromatid exchange: a sensitive measure of DNA damage.
Topics: 4-Nitroquinoline-1-oxide; Animals; Bromodeoxyuridine; Caffeine; Chromosomes; Crossing Over, Genetic; Cytarabine; Daunorubicin; DNA; Drug Evaluation, Preclinical; Ethyl Methanesulfonate; Genetic Techniques; Male; Methylnitronitrosoguanidine; Mice; Mice, Inbred C57BL; Mitomycins; Mutagens; X-Rays | 1979 |
Radiation induction of endogenous type C virus from mouse cells transformed in vitro by murine sarcoma virus.
Topics: 4-Nitroquinoline-1-oxide; Bromodeoxyuridine; Cell Transformation, Neoplastic; Clone Cells; Dose-Response Relationship, Radiation; Retroviridae; Sarcoma Viruses, Murine; Time Factors; Ultraviolet Rays; Virus Replication; X-Rays | 1979 |
The effect of factors causing induction of DNA breaks on transfection of chicken cells by the XC DNA, and the kinetics of appearance of virus-producing cells after transfection.
Topics: 4-Nitroquinoline-1-oxide; Animals; Avian Sarcoma Viruses; Bromodeoxyuridine; Cell Transformation, Viral; Cells, Cultured; Chickens; DNA, Viral; Fibroblasts; Light; Transfection | 1979 |
Influence of treatment to sacrifice time and the presence of BrdUrd on chemically-induced aberration rates in mouse marrow cells.
Topics: 4-Nitroquinoline-1-oxide; 9,10-Dimethyl-1,2-benzanthracene; Animals; Bone Marrow Cells; Bromodeoxyuridine; Cell Division; Chromosome Aberrations; Cyclophosphamide; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Mice; Mitomycins; Mutagenicity Tests; Mutagens; Time Factors | 1990 |
Cytogenetic analyses utilizing various clastogens in two sibs with Fanconi anemia, their relatives, and control individuals.
Topics: 4-Nitroquinoline-1-oxide; Adult; Anemia, Aplastic; Bromodeoxyuridine; Cells, Cultured; Child; Child, Preschool; Chromosome Aberrations; Epoxy Compounds; Fanconi Anemia; Female; Humans; Infant; Isoniazid; Lymphocytes; Male; Mutagens; Pedigree; Sister Chromatid Exchange | 1985 |
[Mechanism of the antimutagenic action of interferon: the capacity to protect the human cellular repair system].
Topics: 4-Nitroquinoline-1-oxide; Bromodeoxyuridine; Cells, Cultured; Chromosome Aberrations; Dose-Response Relationship, Radiation; Gamma Rays; Humans; Interferon Type I; Leukocytes; Mutation; Phytohemagglutinins; Sister Chromatid Exchange | 1985 |
DNA excision in repair proficient and deficient human cells treated with a combination of ultraviolet radiation and acridine mustard (ICR-170) or 4-nitroquinoline 1-oxide.
Topics: 4-Nitroquinoline-1-oxide; Bromodeoxyuridine; Cells, Cultured; DNA; DNA Repair; Endonucleases; Fibroblasts; Humans; Nitrogen Mustard Compounds; Nitroquinolines; Photolysis; Ultraviolet Rays; Xeroderma Pigmentosum | 1980 |
X-ray-sensitive mutant mouse cells with various sensitivities to chemical mutagens.
Topics: 4-Nitroquinoline-1-oxide; Animals; Bromodeoxyuridine; Cell Line; Leukemia L5178; Leukemia, Experimental; Methyl Methanesulfonate; Mice; Mutation; Ultraviolet Rays; X-Rays | 1983 |
[Fragile site on chromosome 2 (q11) in a case of familial lymphohistiocytosis].
Topics: 4-Nitroquinoline-1-oxide; Adult; Bromodeoxyuridine; Cells, Cultured; Chromosome Fragile Sites; Chromosome Fragility; Chromosomes, Human, 1-3; Distamycins; Female; Humans; Infant; Interferon Type I; Karyotyping; Lymphatic Diseases; Lymphocytes; Lymphocytosis; Male; Methyl Methanesulfonate | 1984 |
Studies of mutagenicity on quiescent and proliferating hamster cell populations.
Topics: 4-Nitroquinoline-1-oxide; Animals; Bromodeoxyuridine; Cell Cycle; Cell Division; Cell Line; Cricetinae; Ethyl Methanesulfonate; Histidinol; Interphase; Methylnitronitrosoguanidine; Mutagens; Time Factors | 1980 |
The combined action of chemical carcinogens on DNA repair in human cells.
Topics: 2-Acetylaminofluorene; 4-Nitroquinoline-1-oxide; Bromodeoxyuridine; Carcinogens; Cells, Cultured; DNA Repair; Ethyl Methanesulfonate; Fibroblasts; Humans; Methyl Methanesulfonate; Photochemistry; Ultraviolet Rays | 1980 |
Studies on three mutagen-sensitive mutants of mouse L5178Y cells. I. Characterization of the hybrids between L5178Y and mutagen-sensitive mutants.
Topics: 4-Nitroquinoline-1-oxide; Animals; Bromodeoxyuridine; Drug Resistance; Hybrid Cells; Leukemia L5178; Leukemia, Experimental; Methyl Methanesulfonate; Mice; Mutagens; Phenotype; Radiation Tolerance; Thioguanine; Ultraviolet Rays; X-Rays | 1982 |
Nucleolar organizer regions in tongue carcinomas induced in rats: comparison with DNA cytofluorometric analysis.
Topics: 4-Nitroquinoline-1-oxide; Aneuploidy; Animals; Bromodeoxyuridine; Carcinoma, Squamous Cell; Diploidy; DNA, Neoplasm; Epithelium; Flow Cytometry; Male; Nucleolus Organizer Region; Papilloma; Polyploidy; Rats; Rats, Sprague-Dawley; Silver; Staining and Labeling; Tongue Neoplasms | 1994 |
Inhibition of 4-nitroquinoline-1-oxide-induced rat oral carcinogenesis by dietary exposure of a new retinoidal butenolide, KYN-54, during the initiation and post-initiation phases.
Topics: 4-Butyrolactone; 4-Nitroquinoline-1-oxide; Animals; Anticarcinogenic Agents; Biogenic Polyamines; Bromodeoxyuridine; Carcinogens; Cell Division; Male; Mouth Neoplasms; Nuclear Proteins; Nucleolus Organizer Region; Precancerous Conditions; Rats; Rats, Inbred F344; Retinoids; Silver Staining | 1995 |
Assessment of bromodeoxyuridine-labeled S-phase cells in experimentally induced precancerous lesions in the rat's tongue.
Topics: 4-Nitroquinoline-1-oxide; Animals; Bromodeoxyuridine; Carcinoma in Situ; Carcinoma, Squamous Cell; Cell Count; Cell Division; Epithelium; Hyperplasia; Leukoplakia, Oral; Male; Neoplasm Invasiveness; Papilloma; Precancerous Conditions; Rats; Rats, Sprague-Dawley; S Phase; Tongue Neoplasms | 1994 |
Estimation of proliferative activity of experimental tongue carcinoma in rats. Immunohistochemical and DNA cytofluorometric analysis.
Topics: 4-Nitroquinoline-1-oxide; Animals; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Diploidy; Epithelium; Flow Cytometry; G2 Phase; Immunohistochemistry; Male; Mitosis; Papilloma; Polyploidy; Rats; Rats, Sprague-Dawley; S Phase; Tongue Neoplasms | 1993 |
Chemopreventive effect of a xanthine oxidase inhibitor, 1'-acetoxychavicol acetate, on rat oral carcinogenesis.
Topics: 4-Nitroquinoline-1-oxide; Animals; Anticarcinogenic Agents; Benzyl Alcohols; Biogenic Polyamines; Bromodeoxyuridine; Carcinogens; Cell Division; Dose-Response Relationship, Drug; Enzyme Inhibitors; Male; Mouth Mucosa; Nucleolus Organizer Region; Precancerous Conditions; Rats; Rats, Inbred F344; Silver Staining; Terpenes; Tongue; Tongue Neoplasms; Xanthine Oxidase | 1996 |
Chemoprevention of 4-nitroquinoline 1-oxide-induced rat oral carcinogenesis by the dietary flavonoids chalcone, 2-hydroxychalcone, and quercetin.
Topics: 4-Nitroquinoline-1-oxide; Animals; Anticarcinogenic Agents; Biogenic Polyamines; Body Weight; Bromodeoxyuridine; Chalcone; Chalcones; Male; Mouth Neoplasms; Precancerous Conditions; Quercetin; Rats; Rats, Inbred F344 | 1996 |
Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by citrus auraptene in rats.
Topics: 4-Nitroquinoline-1-oxide; Animals; Anticarcinogenic Agents; Bromodeoxyuridine; Carcinogens; Coumarins; Glutathione Transferase; Liver; Male; Mouth Mucosa; NAD(P)H Dehydrogenase (Quinone); Pilot Projects; Polyamines; Precancerous Conditions; Rats; Rats, Inbred F344; Tongue Neoplasms | 1998 |
Ki-67 (MIB 5) immunostaining of mouse lung tumors induced by 4-nitroquinoline 1-oxide.
Topics: 4-Nitroquinoline-1-oxide; Adenocarcinoma; Adenoma; Animals; Antibodies, Monoclonal; Bromodeoxyuridine; Carcinogens; Cell Count; Cell Division; Immunoenzyme Techniques; Ki-67 Antigen; Lung Neoplasms; Male; Mice; Mice, Inbred A; Recombinant Proteins | 1998 |
A novel flow cytometric technique for drug cytotoxicity gives results comparable to colony-forming assays.
Topics: 4-Nitroquinoline-1-oxide; Antimetabolites; Antineoplastic Agents, Phytogenic; Benzimidazoles; Bromodeoxyuridine; Camptothecin; Carcinogens; Cell Division; Cell Line; Cell Survival; Fibroblasts; Flow Cytometry; Fluorescent Dyes; Humans; Lymphocytes; Stem Cells; Werner Syndrome | 2002 |
Inhibitory effects of troglitazone, a peroxisome proliferator-activated receptor gamma ligand, in rat tongue carcinogenesis initiated with 4-nitroquinoline 1-oxide.
Topics: 4-Nitroquinoline-1-oxide; Animals; Antineoplastic Agents; Bromodeoxyuridine; Carcinogens; Chromans; Cyclin D1; Cyclooxygenase 2; DNA-Binding Proteins; Incidence; Isoenzymes; Ligands; Male; Precancerous Conditions; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred F344; Receptors, Cytoplasmic and Nuclear; Thiazolidinediones; Tongue; Tongue Neoplasms; Transcription Factors; Troglitazone; Tumor Cells, Cultured | 2003 |
Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice.
Topics: 4-Nitroquinoline-1-oxide; Animals; Bromodeoxyuridine; Carcinogens; Carcinoma, Papillary; Carcinoma, Squamous Cell; Cyclin-Dependent Kinase Inhibitor p16; Disease Models, Animal; ErbB Receptors; Esophageal Neoplasms; Female; Immunoenzyme Techniques; Keratin-14; Keratins; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mouth Neoplasms; Neoplasm Invasiveness; Tongue Neoplasms | 2004 |
Exploring Synergy between Classic Mutagens and Antibiotics To Examine Mechanisms of Synergy and Antibiotic Action.
Topics: 2-Aminopurine; 4-Nitroquinoline-1-oxide; Anti-Bacterial Agents; Azacitidine; Bromodeoxyuridine; Chloramphenicol; Ciprofloxacin; Cytidine; DNA Breaks, Double-Stranded; Drug Synergism; Erythromycin; Escherichia coli; Gentamicins; Microbial Sensitivity Tests; Mutagens; Tetracycline; Trimethoprim; Vancomycin | 2015 |